 |
Edouard Azzam, Ph.D.
My laboratory studies the effects and underlying mechanisms of low dose ionizing radiation in normal human cells, with particular interest in the radiation-induced bystander effect and the radiation-induced adaptive response. |
 |
Satnam Banga, Ph.D.
We have been studying human diploid fibroblasts(HF) to understand the mechanism of multi-step carcinogenesis ("transformation") of such cells in culture and its effect on cellular aging. |
 |
Betsy Barnes, Ph.D.
The long-term research goal of my laboratory is to characterize the cellular pathways that are regulated by the IRF family of transcription factors. |
 |
Lawrence Harrison, M.D., Ph.D.
Our laboratory is establishing a murine model of colon carcinomatosis and intraperitoneal tumor growth that can serially be evaluated using a noninvasive real-time in vivo bioluminescent imaging method. |
 |
Utz Herbig , Ph.D.
Our lab is studying whether telomere induced senescence contributes to tumor suppression and organismal aging in mammals. |
 |
Roger Howell, Ph.D.
The research in my laboratory focuses on the biological effects of radioactive materials as they relate to both radiation protection and radiation therapy. |
 |
Sergei Kotenko, Ph.D.
Research in my lab is aimed to advance our knowledge of the complex role played by various cytokines in the regulation of the immune response to and in the pathogenesis of a number of diseases including cancer
|
 |
Deborah Lazzarino, Ph.D.
My work focuses on the identification and characterization of early progenitor and stem cells in mouse mammary glands in normal and oncogenic development. |
 |
Steven Levison, Ph.D.
The overall goal of my research program is to better understand the signals that regulate the proliferation and differentiation of the stem cells in the central nervous system. |
 |
Hong Li , Ph.D.
One of the goals of my laboratory is to develop and optimize mass spectrometry technologies to study the role of protein post-translational modifications and protein-protein interactions on gene regulation. |
 |
Elizabeth Moran, Ph.D.
We study the molecular mechanisms that regulate the different patterns of gene expression seen in cancer cells compared with their normal counterparts. |
 |
Harvey Ozer, M.D.
We study how altered cellular gene expression is responsible for immortalization, my lab is assessing differences in cDNA libraries between pre-immortal and immortal cells. |
 |
Ian Whitehead, Ph.D.
Our laboratory conducts research in the field of mammalian signal transduction, with a particular interest in small G proteins and their contribution to human cancer. |
 |
Robert Wieder, M.D., Ph.D.
Our laboratory studies the mechanisms of dormancy and resistance to chemotherapy in breast cancer cells that metastasize to the bone marrow. |
 |
Teresa Wood, Ph.D.
A major focus of my laboratory is in determining how hormones and peptide growth factors interact to promote growth, survival and differentiation of breast epithelial cells. |
 |
Lizhao Wu, Ph.D.
My laboratory is primarily interested in understanding how the Rb/E2F pathway and other tumor suppressor/oncogenic pathways control normal development and cancer.
|